ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

2025 Neurotrophic Mechanisms in Health and Disease Gordon Research Conference and Seminar

Completed
Institution
GORDON RESEARCH CONFERENCES, RI
Principal investigator
Bruce D Carter
Funding
$20K
Duration
2025–2026
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary This proposal aims to support junior investigators, post-doctoral fellows, and students to attend the Gordon Research Conference (GRC) on Neurotrophic Mechanisms in Health and Disease at Salve Regina University, Newport, RI, from June 1-6, 2025, along with the preceding Gordon Research Seminar (GRS) on May 31-June 1, 2025 for early career researchers. The conference aims to foster interactions among diverse researchers from all over the world, discuss new approaches and emerging concepts in neurotrophic factor research, and integrate young researchers into the neurotrophic factors' community. Emphasis is placed on diversity, inclusion, and a family-friendly approach, with significant representation of women and under-represented groups among the speakers and targeted efforts to promote attendance from these groups. For over 26 years, this interdisciplinary conference has brought together neuroscientists, cell biologists, and clinicians to lead advancements in molecular, cellular, and developmental neuroscience and translate neurotrophin biology into therapies. Neurotrophic factors play critical roles in nervous system development, including neurogenesis, neuronal survival and death, axon and dendrite growth and pruning, synaptic plasticity, myelination, and behaviour regulation. Emerging research reveals their involvement in stem cell niches, tissue regeneration, neuron-glia/immune signalling, and cancer progression. Neurotrophin signalling mechanisms are increasingly recognized in human developmental disorders, psychiatric disorders, chronic inflammation, and neurodegenerative diseases, with neurotrophin-based treatments now available and in late phase clinical trials.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKER13Special Emphasis Panel[ZNS1 SRB-K (49)]seminarneurotrophicdendritehealth diseasegordon researchresearch seminargordonjune

Questions for GORDON RESEARCH CONFERENCES

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.